Record mula sa primary source
Decision-gradePag-apruba ng FDA
Merck & Co., Inc. · Pinahintulutan ng FDA ang Keytruda Qlex (pembrolizumab at berahyaluronidase alfa-pmph)
FDA's Purple Book lists BLA 761467 (Keytruda Qlex, pembrolizumab at berahyaluronidase alfa-pmph; Merck Sharp & Dohme LLC, CDER) as licensed on 2025-09-19.
Mahahalagang fact
- Na-file
- Set 19, 2025, 12:00 AM
- Kaganapan
- Pag-apruba ng FDA
- Direksyon
- Positibo
- Kumpanya
MRKMSD- Asset
- pembrolizumab
- Pinagmulan
- Pinagmulan
- Kumpiyansa
- May source